Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Velan Inc T.VLN

Alternate Symbol(s):  VLNSF

Velan Inc. is a Canada-based manufacturers of industrial valves. The Company designs, manufactures and markets a range of industrial valves for use in industry applications, including power generation, oil and gas, refining and petrochemicals, chemicals, liquid natural gas and cryogenics, pulp and paper, geothermal processes and shipbuilding. Its products include Quarter-turn valves, Gate, globe, and check valves, Cryogenic valves, HF Acid valves, Steam traps, Bellows seal valves and Velan ABV Valves. Its services include research and development, maintenance manuals (IOMs), spare parts and service locations. The North American operations comprising two manufacturing plants in Canada, as well as one manufacturing plant and one distribution facility in the United States. Its overseas operations include manufacturing plants in France, Italy, Portugal, Korea, Taiwan, India, and China. The Company’s operations also include a sales operation in Germany.


TSX:VLN - Post by User

Post by screamer99on May 19, 2022 8:59am
308 Views
Post# 34694851

Q4 results - shaking my head

Q4 results - shaking my headWhat the company doesn't present / mention:

1. The EBITDA of $16m is substantially all from the net gain on the sale of the JV interest.

2. With the above, EBITDA would have been break-even for the quarter.

3. What they did is bury a "long-term" provision of $13m related to the claims that was first recorded in Q4. They've finally acknoweldged there should have been something recorded in the accounts related to future claims which was the subject of my previous posts, but this is amount is a fraction of the potential liability.

Without the above provision, cash claims costs are around $6m which is higher than last year.

4. No mention of the number of claims settled in the quarter or how many remain to be settled. This is a major red flag IMHO. If trends were improving (e.g., claims decreasing or cost per claim decreasing), they would have presented the info.

With the order backlog > 12 months returning to historical norms, I'm expecting a neutral year next year (but still profitable). With the backlog informaiton provided over the last 4 - 6 quarters, no doubt this year was going to be a record year. Can it be repeated? I don't think so.

When you realize the company's cash balance is funded by customer deposits, the cash position isn't as impressive.

Obviously plenty of cautionary notes here and with less information disclosed, I'm continuing to wait on the sidelines. Good luck to those who continue to hold.
<< Previous
Bullboard Posts
Next >>